What is our method for cryopreservation?
We utilise a cryopreservation method from Japan to vitrify and thaw oocytes and embryos at any developmental stage. This method consistently achieves high post-thaw survival rates for embryos and blastocysts to maximise your clinical outcomes.
One of the main advantages of cryopreserving embryos is to salvage all available embryos in a stimulated cycle. This means that these embryos can be opted for transfer in a later frozen cycle, increasing the chances of achieving pregnancy from a single egg retrieval. The additional benefits extend to the flexibility of preparing the uterus for optimal receptivity and by lowering the occurrence of OHSS.
The “freeze-all embryo strategy” is commonly implemented and is made possible by the efficient freeze-thaw survival rates by such vitrification systems.
Features of this cryopreservation method
- Consistent 99.9% survival of embryos and blastocysts when the protocol is strictly adhered to.
- Minimal damage to oocytes or embryos ensuring that they are not adversely affected by the process of cryopreservation.
- A simple and easy-to-learn protocol for trained embryologists. Our embryologists are trained and certified by the training division of the manufacturer to yield repeatable survival results.
- Also effective to most eggs and embryos with poorer quality, such as eggs from older patients.
As part of the Alpha IVF Group which utilised this cryopreservation method since 2013, we observed 99.9% post-thaw survival rates for embryos and blastocysts.